"Pharmaceutical Injecting Device, Display Control Method for Pharmaceutical Injecting Device, and Injection Site Display Device" in Patent Application Approval Process (USPTO 20170056605)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors KONDO, Tsuguhiro (Ehime, JP); KIKUCHI, Seiji (Ehime, JP); MUKAI, Yasutaka (Ehime, JP), filed on March 23, 2015, was made available online on March 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents (see also Patents).
This patent application has not been assigned to a company or institution.
The following quote was obtained by the news editors from the background information supplied by the inventors: "A conventional pharmaceutical injecting device of this type was configured as follows.
"Specifically, the configuration comprised a main body case having a pharmaceutical syringe installation component, a piston provided movably with respect to the pharmaceutical syringe installed in this pharmaceutical syringe installation component, drive mechanism that drives this piston, a controller that is electrically connected to this drive mechanism, and a display component that is connected to this controller."
In addition to the background information obtained for this patent application, NewsRx journalists also obtained the inventors' summary information for this patent application: "In the above-mentioned conventional example, the patient himself injects a pharmaceutical into his own body by his own operation. This is often used, for example, for injecting growth hormone into a child. The growth hormone is injected every other day, for example, but if it is always injected at the same site, that site can undergo an injection site reaction that causes redness, swelling, and itching.
"However, particularly in the case of a child, the patient often ends up always injecting at a site that is easy for him to inject. Consequently, continuous injection at the same site ends up causing problems.
"In view of this, it is an object of certain implementations of the present invention to provide a pharmaceutical injecting device, a display control method for a pharmaceutical injecting device, and an injection site display device, with which problems are less likely to be caused by continuous injection at the same site.
"To achieve this object, certain implementations of the present invention comprise a main body case, a piston, a drive mechanism, a display component, and a display controller. The main body case has a pharmaceutical syringe installation component in which a pharmaceutical syringe is installed. The piston is provided movably with respect to the pharmaceutical syringe installed in the pharmaceutical syringe installation component. The drive mechanism drives the piston. The display component displays injection sites at which the pharmaceutical in the pharmaceutical syringe is injected. The display controller causes the display component to display a plurality of the injection sites and to display at two or more injection sites selectable displays indicating that those injection sites are suitable for injection. This achieves the stated object.
"As discussed above, the display controller of certain implementations of the present invention causes the display component to display a plurality of the injection sites and to display at two or more injection sites selectable displays indicating that those injection sites are suitable for injection.
"Accordingly, since selectable displays are displayed at two or more injection sites, the patient can choose a site each time that affords easy injection from among the injection sites displayed in selectable form. Furthermore, the site the patient chooses will be an injection site that is suitable for injection, that is, one at which continuous injection is unlikely to pose a problem.
"Therefore, even if the patient is a child, he can inject at a site where injection is easy for him, and can be guided to inject at a site where continuous injection is unlikely to pose a problem.
"As a result, problems caused by continuous injection at the same site are less likely to occur."
URL and more information on this patent application, see: KONDO, Tsuguhiro; KIKUCHI, Seiji; MUKAI, Yasutaka. Pharmaceutical Injecting Device, Display Control Method for Pharmaceutical Injecting Device, and Injection Site Display Device. Filed March 23, 2015 and posted March 9, 2017. Patent URL: http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220170056605%22.PGNR.&OS=DN/20170056605&RS=DN/20170056605
Keywords for this news article include: Patents, Hormones.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC